Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recombinant allergens for skin testing.

P Schmid-Grendelmeier1, R Crameri

  • 1Swiss Institute of Allergy and Asthma Research (SIAF), Davos, Switzerland. peter-schmid@hin.ch

International Archives of Allergy and Immunology
|July 4, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The International Guideline for the Definition, Classification, Diagnosis and Management of Urticaria.

Allergy·2026
Same author

Shaping the Future of Respiratory Care: A Look Into the Next Decade and Strategic Recommendations by the European Forum for Research and Education in Allergy and Airways Diseases.

Chest·2026
Same author

Raising the bar in respiratory care by EUFOREA: report of the European Union Parliament Symposium, April 2024.

Frontiers in allergy·2025
Same author

EUFOREA summit in Brussels 2023: <i>inspiring the future of allergy & respiratory care</i>.

Frontiers in allergy·2023
Same author

How to integrate atopic dermatitis in the management of skin neglected tropical diseases in Sub-Saharan Africa?

Journal of the European Academy of Dermatology and Venereology : JEADV·2023
Same author

Position statement: Recommendations on the diagnosis and treatment of Malassezia folliculitis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023
Same journal

Differences in Reported Anaphylaxis Associated With Common Nonsteroidal Anti-inflammatory Drugs: A Pharmacovigilance Study.

International archives of allergy and immunology·2026
Same journal

Association of Serum Galectin-3 Binding Protein with Acute Exacerbation, Inflammation, and Airway Remodeling in Pediatric Asthma.

International archives of allergy and immunology·2026
Same journal

Effectiveness of a Provincial Law to Improve Epinephrine Use for Anaphylaxis in Schools in Alberta, Canada: A Pre-Post Study.

International archives of allergy and immunology·2026
Same journal

Rab27 a regulates dendritic cell immune tolerogenic capacity.

International archives of allergy and immunology·2026
Same journal

Burden of Hereditary Angioedema in Adults: Impact of Disease and Patient Characteristics.

International archives of allergy and immunology·2026
Same journal

Predictors of Treatment Response to Omalizumab in Children with Chronic Spontaneous Urticaria: A Real World Study.

International archives of allergy and immunology·2026
See all related articles

Recombinant allergens (rAllergens) offer a more reproducible and safer method for skin testing compared to traditional extracts. Panels of rAllergens enhance diagnostic sensitivity for allergic conditions.

Area of Science:

  • Allergy diagnostics
  • Immunotherapy
  • Biotechnology

Background:

  • Skin testing is crucial for diagnosing immediate-type allergic reactions.
  • Standardized allergen extracts lack reproducibility due to natural source variability.
  • Recombinant DNA technology enables consistent production of high-purity allergens.

Purpose of the Study:

  • To review and analyze literature on skin testing with recombinant allergens (rAllergens).
  • To assess the safety, specificity, and sensitivity of rAllergens in diagnostic skin tests.
  • To explore the potential of rAllergens in personalized immunotherapy.

Main Methods:

  • Literature review of studies using rAllergens in skin prick tests and intradermal tests.
  • Analysis of data from over 1,600 allergic and control individuals.

Related Experiment Videos

  • Evaluation of rAllergen panels for diagnostic sensitivity.

    • Main Results:

    • Skin testing with rAllergens is highly specific and safe.
    • Single rAllergens show lower sensitivity than extracts, but panels improve this.
    • Quantitative testing with rAllergens provides insights into sensitization patterns.

    Conclusions:

    • rAllergens provide a specific and safe diagnostic tool for allergy.
    • rAllergen testing aids in understanding patient-specific sensitization.
    • This technology supports the development of tailored immunotherapies.